overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Drug Information

Indication: Symptomatic treatment of urgency, increased micturition frequency &/or urgency incontinence as may occur i...

Indication: Overactive bladder w/ symptoms of urinary urgency, frequency or urge incontinence.

Indication: Symptomatic treatment of urge incontinence &/or increased urinary frequency & urgency.

Indication: Symptomatic treatment of urge incontinence &/or increased urinary frequency & urgency in patients w/ o...

Botox
clostridium botulinum toxin type A

Indication: Blepharospasm associated w/ dystonia, including benign essential blepharospasm, hemifacial spasm, VIIth nerve ...

Indication: Overactive bladder w/ symptoms of urge, urinary incontinence, urgency & frequency.

Dysport
botulinum A toxin

Indication: Symptomatic treatment of focal spasticity of upper limbs in adults & dynamic equinus foot deformity in amb...

Toviaz
fesoterodine fumarate

Indication: Overactive bladder w/ symptoms of urge urinary incontinence, urgency & frequency.

Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Roshini Claire Anthony, Yesterday

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 4 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.